GENEXINE Trademark

Trademark Overview


On Monday, December 15, 2014, a trademark application was filed for GENEXINE with the United States Patent and Trademark Office. The USPTO has given the GENEXINE trademark a serial number of 79164375. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, February 3, 2021. This trademark is owned by GENEXINE Co., Ltd.. The GENEXINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines; crude medicines research; research on adult diseases; bacteriological research; research on cancer; pharmaceutical products development; pharmaceutical products research; pharmaceutical products evaluation; consultancy pertaining to pharmacology; medical product testing; research for medical products; medical research; clinical trials; research and development of DNA chips; structural and functional analysis of genomes; biotechnology research; advisory services relating to biotechnology; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; testing/inspection or research on pharmaceuticals/cosmetics or food
genexine

General Information


Serial Number79164375
Word MarkGENEXINE
Filing DateMonday, December 15, 2014
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, February 3, 2021
Registration Number4806220
Registration DateTuesday, September 8, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2015

Trademark Statements


Goods and ServicesResearch and development of vaccines and medicines; crude medicines research; research on adult diseases; bacteriological research; research on cancer; pharmaceutical products development; pharmaceutical products research; pharmaceutical products evaluation; consultancy pertaining to pharmacology; medical product testing; research for medical products; medical research; clinical trials; research and development of DNA chips; structural and functional analysis of genomes; biotechnology research; advisory services relating to biotechnology; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; testing/inspection or research on pharmaceuticals/cosmetics or food

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, May 9, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenexine, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 13488
KR

Party NameGenexine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameGENEXINE Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, May 14, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 8, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Thursday, May 7, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, May 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 9, 2015ASSIGNED TO EXAMINER
Wednesday, May 13, 2015APPLICATION FILING RECEIPT MAILED
Wednesday, June 3, 2015NOTICE OF PUBLICATION
Tuesday, June 23, 2015PUBLISHED FOR OPPOSITION
Friday, June 26, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, September 8, 2015REGISTERED-PRINCIPAL REGISTER
Monday, November 16, 2015FINAL DISPOSITION PROCESSED
Monday, November 16, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 4, 2015NOTIFICATION PROCESSED BY IB
Thursday, May 28, 2020NEW REPRESENTATIVE AT IB RECEIVED
Monday, November 30, 2020TEAS SECTION 71 RECEIVED
Monday, February 1, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 3, 2021NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sunday, September 8, 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, February 3, 2021REGISTERED-SEC.71 ACCEPTED
Friday, October 25, 2024TEAS SECTION 71 RECEIVED